Mucosal leishmaniasis due to Leishmania (Viannia) panamensis in Colombia.: Clinical characteristics

被引:74
作者
Osorio, LE [1 ]
Castillo, CM [1 ]
Ochoa, MT [1 ]
机构
[1] Ctr Int Entrenamiento & Invest Med, Cali, Colombia
关键词
D O I
10.4269/ajtmh.1998.59.49
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The Leishmaniases are a group of diseases whose clinical presentation is in part determined by the infecting species. Until recently, mucosal leishmaniasis was attributed exclusively to Leishmania (Viannia) braziliensis; however, the capacity of other species of the subgenus Viannia to invade mucosal tissue has been documented. This report examines the clinical characteristics of 23 parasitologically diagnosed patients with mucosal leishmaniasis due to L. (V.) panamensis from the Pacific Coast of Colombia seen at CIDEIM between 1985 and 1996. Most of the mucosal lesions 74% (17 of 23) were mild, with a short time of evolution (median = 2.5 months) and were present concomitantly with an active cutaneous lesion in 61% (14 of 23) of the cases. The simultaneous presentation of mucosal and active cutaneous lesions contrast with classical descriptions of mucosal leishmaniasis caused by L. (V.) braziliensis, and highlights the importance of early diagnosis of mucosal disease by the examination of mucosa in all cases of cutaneous leishmaniasis.
引用
收藏
页码:49 / 52
页数:4
相关论文
共 23 条
[1]   CLINICAL CHARACTERISTICS OF HUMAN LEISHMANIA-BRAZILIENSIS-BRAZILIENSIS INFECTIONS [J].
CUENTAS, EAL ;
CUBA, CC ;
BARRETO, AC ;
MARSDEN, PD .
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1984, 78 (06) :845-846
[2]   AMERICAN CUTANEOUS AND MUCOCUTANEOUS LEISHMANIASIS (TEGUMENTARY) - A DIAGNOSTIC CHALLENGE [J].
ESCOBAR, MA ;
MARTINEZ, F ;
SMITH, DS ;
PALMA, GI .
TROPICAL DOCTOR, 1992, 22 :69-78
[3]   EFFICACY AND TOXICITY OF SODIUM STIBOGLUCONATE FOR MUCOSAL LEISHMANIASIS [J].
FRANKE, ED ;
WIGNALL, FS ;
CRUZ, ME ;
ROSALES, E ;
TOVAR, AA ;
LUCAS, CM ;
LLANOSCUENTAS, A ;
BERMAN, JD .
ANNALS OF INTERNAL MEDICINE, 1990, 113 (12) :934-940
[4]   LEISHMANIASES OF THE NEW-WORLD - CURRENT CONCEPTS AND IMPLICATIONS FOR FUTURE-RESEARCH [J].
GRIMALDI, G ;
TESH, RB .
CLINICAL MICROBIOLOGY REVIEWS, 1993, 6 (03) :230-250
[5]   A REVIEW OF THE GEOGRAPHIC-DISTRIBUTION AND EPIDEMIOLOGY OF LEISHMANIASIS IN THE NEW-WORLD [J].
GRIMALDI, G ;
TESH, RB ;
MCMAHONPRATT, D .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1989, 41 (06) :687-725
[6]   PRESENCE OF LEISHMANIA-BRAZILIENSIS IN BLOOD-SAMPLES FROM CURED PATIENTS OR AT DIFFERENT STAGES OF IMMUNOTHERAPY [J].
GUEVARA, P ;
ROJAS, E ;
GONZALEZ, N ;
SCORZA, JV ;
ANEZ, N ;
VALERA, M ;
RAMIREZ, JL .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1994, 1 (04) :385-389
[7]   EPIDEMIOLOGY OF AMERICAN CUTANEOUS LEISHMANIASIS DUE TO LEISHMANIA-BRAZILIENSIS-BRAZILIENSIS [J].
JONES, TC ;
JOHNSON, WD ;
BARRETTO, AC ;
LAGO, E ;
BADARO, R ;
CERF, B ;
REED, SG ;
NETTO, EM ;
TADA, MS ;
FRANCA, F ;
WIESE, K ;
GOLIGHTLY, L ;
FIKRIG, E ;
COSTA, JML ;
CUBA, CC ;
MARSDEN, PD .
JOURNAL OF INFECTIOUS DISEASES, 1987, 156 (01) :73-83
[8]   POSSIBLE RISK-FACTORS IN DEVELOPMENT OF MUCOSAL LESIONS IN LEISHMANIASIS [J].
LLANOSCUENTAS, EA ;
MARSDEN, PD ;
CUBA, CC ;
BARRETO, AC ;
CAMPOS, M .
LANCET, 1984, 2 (8397) :295-295
[9]  
Marsden P. D., 1984, Revista da Sociedade Brasileira de Medicina Tropical, V17, P179, DOI 10.1590/S0037-86821984000400004